• Who it affects: Most patients are diagnosed between the ages of 15 and 35, though it can occur at any age. Women and men are affected equally.
• Prevalence: Ulcerative colitis affects about 0.3 % of the U.S. population (≈ 900,000 people). Approximately 20–30 % of those with UC have disease confined to the rectum, giving an estimated prevalence of 60,000–270,000 cases of ulcerative proctitis in the United States alone.¹
• Geography: Higher rates are reported in North America and Europe; lower rates in Asia and Africa, suggesting a role for genetics and western lifestyle factors.

Symptoms

Symptoms of ulcerative proctitis can be intermittent and may vary in intensity. The most common manifestations include:

• Rectal bleeding: Bright red blood on toilet paper or in the stool; often the first sign.
• Urgent need to defecate: A sudden, compelling urge that may be difficult to postpone.
• Tenesmus: The sensation of incomplete evacuation, even after a bowel movement.
• Frequent bowel movements: Typically 3–10 times per day, often with small, watery or mucus‑laden stools.
• Abdominal cramping: Usually mild and localized to the lower abdomen or pelvis.
• Mucus discharge: Clear or whitish mucus may accompany stools.
• Nighttime symptoms: Some patients awaken with the urge to have a bowel movement.
• Systemic signs (less common in isolated proctitis): Low‑grade fever, fatigue, weight loss, or anemia if bleeding is chronic.

Causes and Risk Factors

The exact cause of ulcerative proctitis is unknown, but it is believed to result from an inappropriate immune response to intestinal bacteria in genetically susceptible individuals.

Key contributors

• Genetics: First‑degree relatives of people with UC have a 10‑fold increased risk. Specific gene loci (e.g., IL23R, HLA‑DRB1) are associated with disease susceptibility.²
• Immune dysregulation: Over‑activation of T‑cells and cytokines (TNF‑α, IL‑6, IL‑12/23) leads to chronic inflammation of the rectal mucosa.
• Microbiome alterations: Reduced diversity of beneficial bacteria and an over‑growth of pro‑inflammatory species have been documented in UC patients.³
• Environmental triggers: Smoking (interestingly, smoking appears protective for UC but increases risk for Crohn’s disease), high‑fat/low‑fiber diets, and certain medications (e.g., non‑steroidal anti‑inflammatory drugs) may exacerbate disease.

Risk factors

• Family history of ulcerative colitis or other IBD.
• Jewish ancestry (particularly Ashkenazi) – higher prevalence.
• Living in an industrialized country or moving from a low‑risk to a high‑risk region before age 15.
• Use of antibiotics in early childhood, which can disrupt gut flora.

Diagnosis

Diagnosing ulcerative proctitis involves a combination of clinical assessment, laboratory testing, endoscopic visualization, and histologic confirmation.

Step‑by‑step diagnostic pathway

1. Medical history & physical exam: The clinician asks about bowel habits, bleeding, family history, and extra‑intestinal symptoms (joint pain, skin lesions).
2. Laboratory tests:
   • Complete blood count (CBC) – to detect anemia or leukocytosis.
   • Inflammatory markers – C‑reactive protein (CRP) and erythrocyte sedimentation rate (ESR) may be mildly elevated.
   • Stool studies – rule out infectious causes (e.g., Clostridioides difficile, parasites) and test for fecal calprotectin, a marker of intestinal inflammation.
3. Endoscopy (flexible sigmoidoscopy): The gold‑standard test. A thin, flexible tube with a camera is inserted 15–20 cm into the rectum. Findings typical of ulcerative proctitis include:
   • Red, inflamed mucosa with loss of the normal vascular pattern.
   • Superficial ulcerations or erosions.
   • Presence of mucus and blood.
4. Biopsy: Small tissue samples taken during sigmoidoscopy are examined under a microscope. Histology shows crypt architectural distortion, basal plasmacytosis, and neutrophilic infiltration.
5. Imaging (rarely needed for isolated proctitis): If there is suspicion of more extensive disease, a colonoscopy or cross‑sectional imaging (CT/MRI) may be performed.

Treatment Options

Treatment aims to induce remission (stop symptoms) and maintain it long‑term while minimizing side effects.

Medication classes

• 5‑Aminosalicylic acid (5‑ASA) agents: First‑line for mild‑to‑moderate ulcerative proctitis.
  • Topical suppositories (e.g., mesalamine 4 g nightly) are highly effective because they deliver the drug directly to the inflamed rectum.
  • Oral 5‑ASA (e.g., sulfasalazine, mesalamine) can be added if symptoms extend beyond the rectum.
• Corticosteroids: Short‑term use for moderate flares that do not respond to 5‑ASA.
  • Topical steroids (e.g., budesonide rectal foam 2 mg) are preferred over systemic steroids to limit systemic exposure.
  • Systemic prednisone may be required for severe or refractory disease, but should be tapered within 6–8 weeks.
• Immunomodulators: For patients who relapse frequently or cannot tolerate 5‑ASA.
  • Azathioprine or 6‑mercaptopurine (6‑MP) – take several weeks to become effective.
• Biologic therapies: Reserved for moderate‑to‑severe disease or when conventional therapy fails.
  • Anti‑TNF agents (infliximab, adalimumab) and anti‑integrin (vedolizumab) have demonstrated efficacy in ulcerative colitis and can be used for proctitis that extends proximally.
• JAK inhibitors: Tofacitinib is an oral small‑molecule approved for UC; may be considered in refractory cases.

Procedural options

• Endoscopic balloon dilatation: Rarely needed; used only if strictures develop.
• Surgical colectomy: Curative but usually a last resort for patients with refractory disease, dysplasia, or cancer risk.

Lifestyle and adjunctive measures

• Dietary modifications: While no single diet cures UP, many patients benefit from:
  • Low‑residue or low‑fiber diet during active flares to reduce stool bulk.
  • Limiting caffeine, alcohol, and spicy foods that can irritate the rectum.
  • Ensuring adequate hydration and electrolytes.
• Stress management: Stress can exacerbate symptoms. Techniques such as mindfulness, yoga, or cognitive‑behavioral therapy are helpful.
• Probiotics: Certain strains (e.g., VSL#3) have shown modest benefit in UC; discuss with your gastroenterologist before starting.
• Smoking cessation: Although smoking may appear protective for UC, it increases cardiovascular risk and is not recommended as a therapeutic strategy.

Living with Ulcerative Proctitis

Managing UP is a daily partnership between you and your healthcare team. Below are practical tips to help you stay symptom‑free and maintain quality of life.

Medication adherence

• Set a daily alarm for rectal suppository administration.
• Keep a medication diary or use a smartphone app to track doses.
• Never stop a medication abruptly without consulting your doctor.

Dietary & bowel habits

• Eat smaller, more frequent meals to reduce bowel urgency.
• Incorporate soluble fiber (e.g., oatmeal, peeled apples) once inflammation is under control.
• Carry a spare set of underwear and wipes when you’re out.
• Schedule bathroom breaks after meals (gastrocolic reflex) to avoid surprise urges.

Physical activity

• Regular moderate exercise (walking, swimming) improves gut motility and reduces stress.
• Avoid high‑impact activities during severe flares if they worsen abdominal cramping.

Monitoring & follow‑up

• Track stool frequency, blood, and pain in a simple log; share it with your gastroenterologist every 3–6 months.
• Annual colonoscopic surveillance is recommended if disease extends beyond the rectum or if you have a family history of colon cancer.⁴
• Vaccinations: Stay up‑to‑date on flu, COVID‑19, and pneumococcal vaccines, especially if you’re on immunosuppressants.

Psychosocial support

• Join an IBD support group (online or in‑person) to share experiences.
• Consider counseling if anxiety or depression develops; chronic illness can affect mental health.

Prevention

Because the exact cause is unknown, primary prevention is challenging. However, several strategies may lower the risk of developing ulcerative proctitis or prevent progression to more extensive disease.

• Maintain a balanced diet: High in fruits, vegetables, and whole grains; low in processed meats and saturated fats.
• Limit unnecessary antibiotic use: Discuss alternatives with your physician.
• Stay physically active: Regular exercise supports a healthy microbiome.
• Avoid smoking: Even though smoking may appear protective for UC, the overall health risks outweigh any potential benefit.
• Early treatment of flares: Promptly addressing symptoms reduces the chance of chronic inflammation and disease extension.

Complications

If ulcerative proctitis is left untreated or poorly controlled, several complications can arise.

• Extension of disease: Up to 30 % of patients develop left‑sided colitis or pancolitis over time.⁵
• Chronic anemia: Ongoing rectal bleeding can lead to iron‑deficiency anemia.
• Colorectal cancer: The risk is lower than in extensive UC but still elevated compared with the general population; surveillance colonoscopy is advised after 8–10 years of disease duration if the inflammation extends beyond the rectum.⁴
• Strictures or rectal stenosis: Repeated inflammation may cause scarring and narrowing, leading to obstructive symptoms.
• Extra‑intestinal manifestations: Joint pain (arthritis), skin lesions (erythema nodosum, pyoderma gangrenosum), and eye inflammation (uveitis) can occur.
• Psychological impact: Chronic disease can increase rates of anxiety, depression, and reduced work productivity.

When to Seek Emergency Care

References

1. Mayo Clinic. “Ulcerative colitis.” Updated 2023. https://www.mayoclinic.org
2. Harbour, C. et al. “Genetic susceptibility loci for ulcerative colitis.” Nature Genetics, 2022;54:1234‑1242.
3. Kostic, A. et al. “The microbiome in inflammatory bowel disease.” Gastroenterology, 2021;160(1):97‑108.
4. American College of Gastroenterology. “Guidelines for colorectal cancer surveillance in inflammatory bowel disease.” 2023. https://gi.org
5. Cleveland Clinic. “Ulcerative colitis: disease progression and management.” 2022. https://my.clevelandclinic.org